Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States from 1988 to 2008.

SciVee ◽  
2011 ◽  
Author(s):  
Zobair Younossi
Keyword(s):  
United States ◽  
Liver Diseases ◽  
The United States ◽  
Chronic Liver ◽  
Chronic Liver Diseases ◽  
Common Causes

Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008

2011 ◽  
Vol 9 (6) ◽  
pp. 524-530.e1 ◽  
Author(s):  
Zobair M. Younossi ◽  
Maria Stepanova ◽  
Mariam Afendy ◽  
Yun Fang ◽  
Youssef Younossi ◽  
...  
Keyword(s):  
United States ◽  
Liver Diseases ◽  
The United States ◽  
Chronic Liver ◽  
Chronic Liver Diseases ◽  
Common Causes

Financial Hardship from Medical Bills Among Adults with Chronic Liver Diseases: National Estimates from the United States

Hepatology ◽  
2021 ◽  
Author(s):  
Carlos Lago‐Hernandez ◽  
Nghia H. Nguyen ◽  
Rohan Khera ◽  
Rohit Loomba ◽  
Sumeet K. Asrani ◽  
...  
Keyword(s):  
United States ◽  
Liver Diseases ◽  
The United States ◽  
Chronic Liver ◽  
Financial Hardship ◽  
Chronic Liver Diseases ◽  
National Estimates ◽  
Medical Bills

Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Christopher Ma ◽  
Alexander S. Qian ◽  
Nghia H. Nguyen ◽  
Igor Stukalin ◽  
Stephen E. Congly ◽  
...  
Keyword(s):  
United States ◽  
Economic Burden ◽  
Liver Diseases ◽  
The United States ◽  
Chronic Liver ◽  
Chronic Liver Diseases

scholarly journals APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases

2016 ◽  
Vol 242 (3) ◽  
pp. 242-249 ◽  
Author(s):  
Charles B Nguyen ◽  
Courtney W Houchen ◽  
Naushad Ali
Keyword(s):  
Liver Diseases ◽  
The United States ◽  
Late Presentation ◽  
Chronic Liver ◽  
Stem Cell Marker ◽  
Cell Subpopulation ◽  
Chronic Liver Diseases ◽  
Clinical Potential ◽  
New Strategies ◽  
Hepatic Tumorigenesis

Liver diseases are the fourth leading cause of mortality among adults in the United States. Patients with chronic liver diseases such as viral hepatitis, fibrosis, and cirrhosis have significantly higher risks of developing hepatocellular carcinoma (HCC). With a dismal five-year survival rate of 11%, HCC is the third most common cause of cancer-related deaths worldwide. Regardless of the underlying cause, late presentation and a lack of effective therapy are the major impediments for successful treatment of HCC. Therefore, there is a considerable interest in developing new strategies for the prevention and treatment of chronic liver diseases at the early stages. Cancer stem cells (CSCs), a small cell subpopulation in a tumor, exhibit unlimited self-renewal and differentiation capacity. These cells are believed to play pivotal roles in the initiation, growth, metastasis, and drug-resistance of tumors. In this review, we will briefly discuss pivotal roles of the CSC marker doublecortin-like kinase 1 (DCLK1) in hepatic tumorigenesis. Recent evidence suggests that anti-DCLK1 strategies hold promising clinical potential for the treatment of cancers of the liver, pancreas, and colon.

Helicobacter infection in patients with HCV-chronic liver diseases

2001 ◽  
Vol 120 (5) ◽  
pp. A725-A725
Author(s):  
M DORE ◽  
G REALDI ◽  
D MURA ◽  
D GRAHAM ◽  
A SEPULVEDA
Keyword(s):  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Diseases

TRAF1-C5as risk locus for increased hepatic fibrosis in chronic liver diseases

2008 ◽  
Vol 46 (09) ◽  
Author(s):  
F Grünhage ◽  
A Höblinger ◽  
S Schwartz ◽  
T Sauerbruch ◽  
F Lammert
Keyword(s):  
Hepatic Fibrosis ◽  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Diseases ◽  
Risk Locus

Targeting TGF-β2 in chronic liver diseases

2015 ◽  
Vol 53 (01) ◽  
Author(s):  
A Dropmann ◽  
H Korhonen ◽  
F Jaschinski ◽  
M Janicot ◽  
N Meindl-Beinker ◽  
...  
Keyword(s):  
Liver Diseases ◽  
Chronic Liver ◽  
Chronic Liver Diseases
Sign in / Sign up

Export Citation Format

Share Document